Status:
COMPLETED
A Study to Evaluate the Safety of an Investigational Drug (Etoricoxib) in Patients With Osteoarthritis (OA) or Rheumatoid Arthritis (RA)(0663-066)
Lead Sponsor:
Organon and Co
Conditions:
Rheumatoid Arthritis,Osteoarthritis
Eligibility:
All Genders
50+ years
Phase:
PHASE3
Brief Summary
The study is designed to compare the risk of cardiovascular events (heart attacks, strokes) in patients receiving either etoricoxib or diclofenac. It will also compare the gastrointestinal tolerabilit...
Eligibility Criteria
Inclusion
- Patient has a clinical diagnosis of either Osteoarthritis or Rheumatoid Arthritis and in the opinion of the investigator will require chronic nonsteroidal anti-inflammatory or COX-2 inhibitor therapy for at least 1.5 years
Exclusion
- Concurrent medical or arthritic disease that could confound or interfere with efficacy evaluation.
- Concomitant therapy of warfarin, heparin, high-dose aspirin (\>100 mg/day).
- Impaired kidney function, clinical gastrointestinal malabsorption, congestive heart failure with symptoms that occur at rest, unstable angina, uncontrolled high blood pressure, active hepatitis/hepatic disease
Key Trial Info
Start Date :
January 1 2003
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2006
Estimated Enrollment :
23498 Patients enrolled
Trial Details
Trial ID
NCT00250445
Start Date
January 1 2003
End Date
May 1 2006
Last Update
February 18 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.